Skip to content
Business Segments · Identifiable assets

Diagnostics — Identifiable assets

Danaher Diagnostics — Identifiable assets decreased by 0.6% to $14.66B in Q1 2026 compared to the prior quarter.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2023
Last reportedQ1 2026Apr 21, 2026
Rolls up toTotal Assets

How to read this metric

Growth in assets relative to sales may indicate declining capital efficiency, while stable assets with growing sales indicate improved efficiency.

Detailed definition

The total value of assets that can be directly attributed to the diagnostics segment, including inventory, property, pla...

Peer comparison

Standard segment-level disclosure for diversified corporations.

Metric ID: dhr_segment_diagnostics_identifiable_assets

Historical Data

4 periods
 Q4 '23Q4 '24Q4 '25Q1 '26
Value$14.55B$14.2B$14.75B$14.66B
QoQ Change-2.4%+3.8%-0.6%
YoY Change-2.4%+3.8%
Range$14.2B$14.75B
Avg YoY Growth+0.7%
Median YoY Growth+0.7%

Frequently Asked Questions

What is Danaher's diagnostics — identifiable assets?
Danaher (DHR) reported diagnostics — identifiable assets of $14.66B in Q1 2026.
What does diagnostics — identifiable assets mean?
The total value of all assets specifically used by the diagnostics segment.